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Abstract Optical coherence tomography (OCT) and
scanning laser polarimetry (GDx ECC) are non-invasive
methods used to assess retinal nerve ﬁber layer (RNFL)
thickness, which may be a reliable tool used to monitor
axonal loss in multiple sclerosis (MS). The objectives of
this study are (1) to compare OCT with the GDx ECC;
(2) to assess and compare the RNFL thickness in subgroups
of MS. Ophthalmologic examination and RNFL assessment
by OCT and GDx were performed in 65 MS patients (26
relapsing-remitting (RRMS), ten secondary-progressive
(SPMS), 29 primary-progressive (PPMS)). Twenty-eight
patients (43%) had a history of optic neuritis (ON).
Adjustments were made for age and disease duration.
RNFL thickness was reduced in eyes with previous ON
(p\0.01). No differences were found between PPMS and
relapse-onset MS. OCT and GDx ECC measurements were
moderately correlated (rho = 0.73, p\0.01). Visual ﬁeld-
mean deviation (MD) values correlated with OCT means
(r = 0.44, p\0.01) and GDx ECC TSNIT average
(r = 0.41, p\0.01). In patients without previous ON,
EDSS correlated with MD (r =- 0.36, p\0.01), visual
ﬁeld-pattern standard deviation (PSD) (r = 0.30,
p\0.05), OCT means (r =- 0.31–0.30, p\0.05) and
macular volume (r =- 0.37, p\0.01). For MSIS-29
physical impact score, signiﬁcant correlations were found
with MD (r =- 0.48, p\0.01) and PSD (r = 0.48,
p\0.01). Conclusions: No differences between PPMS and
relapse-onset MS subgroups were found. RNFL thickness
was reduced in eyes with previous ON. Although OCT and
GDx ECC ﬁndings were moderately correlated and showed
signiﬁcant correlations with measures of visual function in
patients without previous ON, EDSS correlated signiﬁ-
cantly with visual and OCT measures, but not with GDx
ECC.
Keywords Multiple sclerosis  Retinal nerve ﬁber layer 
Optical coherence tomography 
Scanning laser polarimetry
Introduction
The central origin of irreversible disability in patients with
multiple sclerosis (MS) lies in axonal loss [1]. Brain atro-
phy on magnetic resonance imaging (MRI) is the most used
marker to monitor disease progression. However, correla-
tions between MRI measurements and clinical disability
are limited [2, 3]. More speciﬁc measures of axonal dam-
age and neuronal loss in MS are needed.
The retina is part of the central nervous system and
easily accessible for clinical examination. The retinal nerve
ﬁber layer (RNFL) is composed predominantly of unmy-
elinated axons of retinal ganglion cells. Measurements of
the RNFL give relatively direct measures of axons and thus
of axonal damage. Optical coherence tomography (OCT)
and scanning laser polarimetry (GDx) are non-invasive
methods used to measure peripapillary retinal nerve ﬁber
layer (RNFL) thickness. Both are established techniques
used in glaucoma, to detect early glaucomatous damage
[4]. OCT measures RNFL thickness by using interference
patterns of backscattered near-infrared light, analogous to
B-scan ultrasound and with an axial resolution of less than
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thickness by using polarized light that undergoes a phase
shift after passing through the RNFL [6]. GDx ECC is a
new device with enhanced corneal compensation (GDx
ECC). It has been introduced to optimize images of RNFL
morphology by improving the signal-to-noise ratio, and
to obtain a better structure–function relationship than
with earlier versions of GDx, the GDx FCC and GDx VCC
[7–9]. Both OCT and GDx analyse and express the average
RNFL thickness in micrometers. However, because of the
difference in technique of both methods, the RNFL mea-
surements of OCT and GDx in microns are not comparable
[5].
Several studies with OCT have demonstrated RNFL
thinning in optic neuritis (ON) [10–12], and MS [13–22].
In patients with optic neuritis or MS, fewer studies have
used GDx [23–25]. Comparative studies on differences
between OCT and GDx RNFL measurements mostly have
been performed in controls, glaucoma [26], and only three
groups published comparisons of the two techniques in MS
patients [27–31]. However, the only studies available on
GDx in MS until now, made use of GDx VCC instead
of the newer software version GDx ECC. From these
groups only one investigated correlations with disability
(EDSS), but not with MS subtype [27, 29, 30]. These
studies comparing OCT with GDx have produced con-
ﬂicting results concerning the discriminating value of both
techniques.
The aim of the present study was (1) to compare the
OCT with GDx ECC; (2) to assess the value of these
techniques in subgroups of MS.
Methods
Participants
Consecutive patients with a diagnosis of MS were recruited
through the Department of Neurology of the Erasmus
Medical Centre (Rotterdam), from December 2004 to
March 2008. Patients were included if the diagnosis was
veriﬁed by one of the senior neurologists based on the
McDonald criteria [32]. For speciﬁc sub-comparison of MS
types, we purposely included a relatively high number of
patients with primary progressive MS (PPMS). Excluded
were patients with ophthalmologic diseases that might
impair or bias OCT and GDx ECC measurements (e.g.
diabetes, primary open angle glaucoma, abnormal discs
with suspicion of normal tension glaucoma, anomaly of the
disc, opacity of cornea or lens, severe nystagmus). The
medical ethical committees of the participating hospitals
approved this study, and all patients gave written informed
consent.
Measurements
All patients underwent a neurological and ophthalmologic
examination. Type of MS (relapse-onset (RRMS/SPMS) or
PPMS, time since ﬁrst symptoms, time since diagnosis,
Expanded Disability Status Scale (EDSS), Multiple Scle-
rosis Impact Scale (MSIS-29) and Multiple Sclerosis
Severity Scale (MSSS) were assessed.
MSIS-29 measures the physical and psychological
impact of MS from the patient’s perspective. The
physical subscale includes 20 items and the psycholog-
ical subscale nine items. Total scores for both subscales
are generated by summing individual items (scored 1–5),
with high scores indicating greater impact [33]. MSSS
corrects EDSS for disease duration (time since ﬁrst
symptoms) by comparing an individual’s disability with
the distribution of scores in cases having equivalent
disease duration [34]. To be able to compare outcome
parameters in different groups, we aimed to match for
disease duration (time since ﬁrst symptoms and time
since diagnosis).
A history of acute ON was determined by self-report and
physician report and conﬁrmed by medical record review.
Eyes with ON in the last 3 months were not included.
Visual testing
All participants underwent a complete ophthalmologic
examination including measurement of visual acuity
(logMAR acuity); intraocular pressure (IOP) measure-
ment by Goldmann applanation tonometry and fundos-
copy, standard automated perimetry (SAP; Humphrey
Field Analyzer (30-2 SITA standard), Carl Zeiss Medi-
tec Inc, Dublin, CA), evaluating visual ﬁeld mean
deviation (MD) and visual ﬁeld pattern standard devia-
tion (PSD).
Retinal imaging: GDx
Both eyes of all participants were imaged with GDx ECC
(released for research purposes in the commercially avail-
able GDx VCC, Carl Zeiss Meditec, Inc., Dublin, CA), to
measure RNFL thickness. Details of the working principle
of the GDx device and GDx ECC have been described
elsewhere [8, 35].
Images were taken through undilated pupils while the
ambient light was left on. Only typical images of high
quality, that is those with a centred optic disc, well-
focused, evenly and justly illuminated throughout the
image, without any motion artefacts, were selected. The
TSNIT RNFL thickness was used as summary parameter
for GDx, furthermore a superior average, inferior average
and nerve ﬁber indicator (NFI) were calculated.
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Participants underwent measurement of RNFL thickness
for both eyes using OCT (Stratus OCT 4.01 software, Carl
Zeiss Meditec, Dublin, CA). The macula volume (macula
thickness) and RNFL thickness 3.4 scan protocol were used
for OCT (we calculated the average of three circumferen-
tial scans for 360 around the optic disc; 256 axial scans;
diameter 3.4 mm). Scanning was performed after phar-
macological dilation. Average RNFL thickness for 360
around the optic disc was recorded as the OCT 3.4 average.
Also, temporal quadrant thickness (316 to 45), superior
quadrant thickness (46 to 135), nasal quadrant thickness
(136 to 225) and inferior quadrant thickness (226 to
315) were measured.
Statistical analyses
Differences between groups on clinical and demographic
characteristics were analysed by independent-samples
t tests (two-tailed), independent-samples Mann–Whitney
test for ordinal data (two-tailed), and the Chi-squared test
for categorical data. The associations between patient
characteristics and ophthalmological test results were
explored using Spearman correlations (rho) and partial
correlations (r). Linear regression analysis was used to
compare scores on the ophthalmological tests between eyes
with and without previous optic neuritis (adjusted for age
and time since diagnosis), and between eyes of patients
with primary progressive MS (PPMS) and relapse-onset
MS (adjusted for age and time since diagnosis). All
analyses were performed using SPSS 12.0, and a p value
lower than 0.05 was considered statistically signiﬁcant.
Results
Study population
The study enrolled 65 patients; 28 of these patients (43%)
had a history of optic neuritis, 20 unilateral and eight
bilateral. For analyses, we included randomly one eye
for patients without ON (37 eyes) and randomly one eye
for patients with a history of bilateral ON (eight eyes). For
patients with a previous unilateral ON (19 eyes) the mea-
surements of the other eye (=fellow eye; 20 eyes) were
included in a sub-analysis. In one patient with a previous
unilateral ON, this eye could not be measured because of
an artefact, and only the fellow eye was included. Three
patients could not be included in the study because of
nystagmus, which interfered with the measurements.
For patient characteristics see Table 1. Fifty-seven per-
cent of the patients had EDSS scores higher than 4.0.
Disease duration (time since ﬁrst symptoms and time since
diagnosis) of patients with relapse-onset MS and PPMS
were not statistically different (p[0.5). Figure 1 shows
average RNFL thickness, TSNIT average measured with
GDx ECC and OCT means, in patients with and without a
previous ON. We included the unaffected fellow eyes in
the group of eyes ‘‘without ON’’ because a sub-analysis did
not show any signiﬁcant differences between measure-
ments of the fellow eyes in comparison with eyes without a
Table 1 Characteristics of the study population
MS type
Total Relapse-onset PP
n 65 (100%) 36 (55%) 29 (45%)
Age (years) 48.5 (11.5) 44.7 (10.2) 53.2 (11.5)
Sex (women) 69% (45) 81% (29) 55% (16)
Time since ﬁrst symptoms (years) 12.5 (7.8) (median
11.5)
12.0 (7.4) (median
10.5)
13.1 (8.3) (median
12.7)
Time since diagnosis (years) 8.6 (7.1) (median 7.4) 9.1 (7.1) (median 8.0) 8.0 (7.2) (median 6.9)
EDSS median (IQR) 6.0 (3.5–6.5) 4.0 (2.0–6.5) 6.0 (4.0–6.5)
MSSS 6.2 (2.5) (median 6.4) 5.4 (2.7) (median 5.9) 7.0 (2.0) (median 7.4)
MSIS-29 physical score 40.6 (26.1) 31.1 (25.0) 52.3 (22.8)
MSIS-29 psychological score 29.2 (21.3) 23.7 (20.4) 36.0 (20.6)
Number of eyes analysed 84 50 34
Eyes with history of optic neuritis/insidious progressive optic
neuropathy
32% (27) 42% (21) 18% (6)
Categorical variables are shown in % (n) and continuous variables in mean (SD), unless otherwise indicated
IQR interquartile range
1656 J Neurol (2010) 257:1654–1660
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ON had reduced RNFL thickness compared to patients
without ON measured with GDx ECC (TSNIT average
43.7 ± 6.4 versus 50.5 ± 6.3; p\0.001) as well as with
OCT (mean 72.2 ± 14.4 versus 89.5 ± 14.2; p\0.001),
adjusted for age and time since diagnosis. Measurements
with OCT and GDx ECC were moderately correlated (MS
eyes total rho = 0.73, p\0.01; MS eyes without previous
ON rho = 0.57, p\0.01; MS eyes with previous ON
rho = 0.79, p\0.01). Figure 2 shows correlations for MS
eyes total. Average RNFL thickness measured with OCT
and GDx ECC showed signiﬁcant correlations with mea-
sures of visual function (visual acuity and visual ﬁeld)
(Table 2). Macular volume measured with OCT was sig-
niﬁcantly reduced in MS eyes with previous ON
(6.3 ± 0.5) in comparison with MS eyes without previous
ON (6.7 ± 0.5; p = 0.001), adjusted for age and time since
diagnosis.
OCT and GDx ECC in different subgroups of MS
Speciﬁcally for this sub-comparison we included a rela-
tively high number of PPMS patients in this study. How-
ever, no signiﬁcant differences were found in RNFL
thickness when comparing eyes of patients with PPMS and
relapse-onset MS. Figure 3 shows results for eyes without
previous ON, adjusted for age and time since diagnosis.
In both subgroups, OCT and GDx measurements were
highly correlated (PPMS rho = 0.73; relapse-onset MS
rho = 0.77, p\0.01).
Relationship between visual measures and disability
EDSS was negatively correlated with measures of visual
ﬁeld and OCT RNFL thickness, for eyes without previous
ON, after adjustment for age. For GDx ECC correlation
with EDSS was not statistically signiﬁcant (Table 3). For
MSIS-29 physical scores, signiﬁcant correlations were
found with visual ﬁeld MD and PSD, after adjustment for
Fig. 1 GDx and OCT measurements for MS eyes without ON and
MS ON eyes. GDx and OCT adjusted for age and time since
diagnosis. nﬁ nerve ﬁber indicator. *p\0.05, **p\0.01,
***p\0.001
Fig. 2 Correlations between OCT and GDx measurements (MS eyes
total). For eyes without ON: rho = 0.57, p\0.01; eyes with ON:
rho = 0.79, p\0.01
Table 2 Correlations between visual function measures and GDx
TSNIT average/OCT average
GDx OCT
LogMAR acuity -0.61 -0.56
Mean deviation (dB) 0.41 0.44
Pattern standard deviation (dB) -0.31 -0.34
Correlations for MS eyes total; all correlations p\0.01
Fig. 3 OCT and GDx in PP and relapse-onset MS. Eyes without
previous ON, adjusted for age and time since diagnosis
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123age (r = 0.48, p\0.01), but MSIS-29 physical scores
showed no correlations with GDx ECC and OCT mea-
surements. After excluding the fellow eyes from the eyes
without previous ON, the same correlations were found.
Discussion
Studies on retinal measures in distinct subgroups are scarce
[18, 20]. The aim of this study was to compare OCT and
GDx ECC in different subgroups of patients with MS, in
assessing RNFL thinning as a measure of axonal loss.
Before interpreting the results in a group of patients in
which a substantial proportion had a history of ON, it
should be noted that we chose to use the ophthalmological
parameters of the previously unaffected eye for comparison
of subgroups of MS and disability. This appears the most
reliable method, as previous inﬂammatory attacks may
confound the natural cause of neurodegeneration in the eye.
Unfortunately, whether only the unaffected eye has been
studied has not always been clearly described in other
publications.
Results of OCT and GDx ECC were correlated to a
moderate extent (rho = 0.73). Both techniques did not
differ in their capacity to distinguish eyes with and without
previous ON, and they both showed good correlations with
measures of visual function. Our a priori idea was to ﬁnd
differences in RNFL thickness between relapse-onset and
PPMS. Regarding the eyes without a history of ON, there
were no differences observed between relapse-onset MS
and PPMS after adjustment for disease duration. Previous
studies have mainly included patients with RRMS, there-
fore studies that included different subgroups of MS are
scarce. One investigation that compared PPMS patients
with SPMS patients showed relatively enhanced thinning
of RNFL in secondary progressive patients [18]. The ﬁrst
group that combined the whole spectrum of disease cour-
ses, studying RRMS, SPMS and PPMS subgroups in
comparison to controls, did not ﬁnd any differences in
average RNFL thickness between the different subgroups
[20]. The fact that in our comparable study we also
observed no differences between relapse-onset and PPMS
may relate to the lack of clear cut differences between
these two disease subtypes [36, 37].
With respect to disability, we showed that EDSS scores
correlated moderately with OCT-assessed RNFL thinning
in MS patients. No correlation was found between EDSS
and the GDx-assessed values. It cannot be excluded that
this is due to the lack of statistical power. Still, the few
other studies after GDx in MS patients also did not ﬁnd
correlations between EDSS and GDx RNFL thickness
[27, 29, 30]. This could lead to a cautious conclusion that
GDx is not the appropriate tool to investigate the correla-
tion between retinal axonal damage and neurological
disability. Also, others have suggested that GDx is less
accurate than OCT for detecting the inﬂammatory and
neurodegenerative components of the MS disease process
[23, 31], perhaps because it was less sensitive in detecting
temporal and nasal quadrant losses in the RNFL previously
[38]. The relation observed here between EDSS and OCT
parametersis inlinewithseveral otherstudiesconcerningthe
correlations with neurological disability [14, 16, 17, 21, 39].
It should be acknowledged that a couple of studies do not
conﬁrm these ﬁndings [18, 22]. Differences between these
studies may well be caused by different compositions of
the included study populations. Our study population had
relatively progressed disease, with a median EDSS of 6.0.
It is known that the EDSS in the higher ranges have poorer
responsiveness because of a ceiling effect [40]. Despite the
indications that RNFL measurements can be a used as a
surrogate marker for neurodegeneration in MS, one should
not forget that in our study conventional visual ﬁeld
parameters showed signiﬁcant correlations with neurolog-
ical function (EDSS and MSIS-29 physical subscore). In
the future it would seem of interest to determine whether
the levels of association between either visual ﬁeld or
retinal parameters and disability are in fact distinct for low
and high disability subgroups of MS patients. Also more
sensitive instruments to determine visual acuity could
provide extra information. A promising measure for visual
acuity in MS patients is the low-contrast Sloan letter acuity
chart [41], which unfortunately has not been used in our
study protocol.
As previous studies that noted clear correlations
between RNFL thickness and EDSS were mostly per-
formed in groups with relatively lower disability (median
around 2.0) [14, 16, 17, 21, 39], one might expect the best
associations between RNFL thickness and neurological
disability in patients with an EDSS in the lower range.
Therefore the use of this novel tool for measuring neuro-
degeneration in MS patients may be optimally used in little
or modestly affected patients. This is especially the group
of patients at whom most current trials are focusing.
Table 3 Age-adjusted correlations (r) between EDSS and visual/
retinal measures
EDSS p
LogMAR acuity -0.02 NS
Mean deviation (dB) -0.36 \0.01
Pattern standard deviation (dB) 0.30 \0.05
GDx TSNIT average -0.20 NS
OCT 3.4 average -0.30 \0.05
Macular volume (OCT) -0.37 \0.01
Correlations for eyes without previous ON
1658 J Neurol (2010) 257:1654–1660
123A recent longitudinal study could not detect disease-related
ongoing loss of retinal axons in 34 progressive MS patients
[42]. Further investigations with longitudinal data are
needed, so that the determinants of the association between
RNFL thinning, visual function disability and axonal loss
can be unravelled.
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